{"id":282130,"date":"2026-10-01T09:35:27","date_gmt":"2026-10-01T04:05:27","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=282130"},"modified":"2026-10-01T09:35:27","modified_gmt":"2026-10-01T04:05:27","slug":"why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/","title":{"rendered":"SYMBIOTEC PHARMALAB (SYMBIOTEC) 52 Week High Streak: Second Straight Session"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/symbiotec\/symbiotec-pharmalab-ltd-share-price-today\">SYMBIOTEC PHARMALAB LTD (SYMBIOTEC)<\/a> share price reached a fresh 52-week high of Rs 1,198.95 today and later stood at Rs 1,173.9, down 0.18% from the previous close. Market cap was Rs 7,353.15 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/symbiotec\/symbiotec-pharmalab-ltd-share-price-today\">SYMBIOTEC PHARMALAB LTD<\/a> has now set a fresh 52-week high for its second straight session, and the cumulative move across this streak stands at 2.58%. The latest peak is Rs 1,198.95, while the stock last traded at Rs 1,173.90.<\/p>\n<p style=\"margin-top:0!important;\">At 01 October 2026 at 9:22 AM IST, the stock was trading below the previous close of Rs 1,176.05 after opening at Rs 1,197.80 and touching a low of Rs 1,168.80. Turnover and market capitalisation place the move in a wider market context, but the key point for readers is different from a one-day breakout: SYMBIOTEC 52 Week High Streak now reflects a two-session sequence of new yearly highs rather than a single intraday print.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#SYMBIOTEC_PHARMALAB_LTD_52_Week_High_Streak_Consecutive_High_Analysis\" title=\"SYMBIOTEC PHARMALAB LTD 52 Week High Streak: Consecutive High Analysis\">SYMBIOTEC PHARMALAB LTD 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#SYMBIOTEC_PHARMALAB_LTD_52_Week_High_Streak_Consecutive_High_Analysis-2\" title=\"SYMBIOTEC PHARMALAB LTD 52 Week High Streak: Consecutive High Analysis\">SYMBIOTEC PHARMALAB LTD 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#What_the_Repeated_52-Week_Highs_Show\" title=\"What the Repeated 52-Week Highs Show\">What the Repeated 52-Week Highs Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#Latest_News_Around_SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC\" title=\"Latest News Around SYMBIOTEC PHARMALAB LTD (SYMBIOTEC)\">Latest News Around SYMBIOTEC PHARMALAB LTD (SYMBIOTEC)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC_Fundamental_Analysis\" title=\"SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis\">SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#Why_Investors_Are_Watching_SYMBIOTEC_PHARMALAB_LTD\" title=\"Why Investors Are Watching SYMBIOTEC PHARMALAB LTD\">Why Investors Are Watching SYMBIOTEC PHARMALAB LTD<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#About_SYMBIOTEC_PHARMALAB_LTD\" title=\"About SYMBIOTEC PHARMALAB LTD\">About SYMBIOTEC PHARMALAB LTD<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#Track_SYMBIOTEC_PHARMALAB_LTD_on_Univest\" title=\"Track SYMBIOTEC PHARMALAB LTD on Univest\">Track SYMBIOTEC PHARMALAB LTD on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#How_many_sessions_has_SYMBIOTEC_PHARMALAB_LTD_been_at_a_fresh_52-week_high\" title=\"How many sessions has SYMBIOTEC PHARMALAB LTD been at a fresh 52-week high?\">How many sessions has SYMBIOTEC PHARMALAB LTD been at a fresh 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#What_is_the_cumulative_move_across_the_SYMBIOTEC_52_Week_High_Streak\" title=\"What is the cumulative move across the SYMBIOTEC 52 Week High Streak?\">What is the cumulative move across the SYMBIOTEC 52 Week High Streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#What_is_the_latest_52-week_high_for_SYMBIOTEC_PHARMALAB_LTD\" title=\"What is the latest 52-week high for SYMBIOTEC PHARMALAB LTD?\">What is the latest 52-week high for SYMBIOTEC PHARMALAB LTD?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#How_did_SYMBIOTEC_PHARMALAB_LTD_trade_around_the_prior_close\" title=\"How did SYMBIOTEC PHARMALAB LTD trade around the prior close?\">How did SYMBIOTEC PHARMALAB LTD trade around the prior close?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#Did_the_latest_data_confirm_a_company-specific_catalyst\" title=\"Did the latest data confirm a company-specific catalyst?\">Did the latest data confirm a company-specific catalyst?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#How_does_SYMBIOTEC_compare_with_the_industry_on_valuation\" title=\"How does SYMBIOTEC compare with the industry on valuation?\">How does SYMBIOTEC compare with the industry on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#What_should_investors_monitor_next_in_SYMBIOTEC_52_Week_High_Streak\" title=\"What should investors monitor next in SYMBIOTEC 52 Week High Streak?\">What should investors monitor next in SYMBIOTEC 52 Week High Streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#Why_is_the_repeated_52-week_high_more_important_than_a_one-day_breakout\" title=\"Why is the repeated 52-week high more important than a one-day breakout?\">Why is the repeated 52-week high more important than a one-day breakout?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-52-week-consecutive-high-2026\/#Track_SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC_Share_Price_on_Univest\" title=\"Track SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Share Price on Univest\">Track SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"SYMBIOTEC_PHARMALAB_LTD_52_Week_High_Streak_Consecutive_High_Analysis\"><\/span><strong>SYMBIOTEC PHARMALAB LTD 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,173.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,176.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -2.15 (-0.18%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,197.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,198.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,168.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,353.15 crore<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) traded at Rs 1,173.9 versus the previous close of Rs 1,176.05, a fall of 0.18%. The stock opened at Rs 1,197.8, reached a high of Rs 1,198.95 and touched a low of Rs 1,168.8.<\/p>\n<p>SYMBIOTEC PHARMALAB LTD was last traded at Rs 1,173.90, down Rs 2.15 or 0.18% versus the previous close of Rs 1,176.05. The stock opened at Rs 1,197.80, touched a high of Rs 1,198.95 and a low of Rs 1,168.80, with the latest price standing nearer the lower end of that range. This is the same level as the fresh 52-week high for the session, so the intraday peak and the yearly peak are aligned. Market capitalisation stood at Rs 7,353.15 crore, which gives scale to the move without saying anything about quality on its own. For readers tracking SYMBIOTEC 52 Week High Streak, the important detail is that the stock has repeated the yearly-high pattern across two sessions while the latest price remained only slightly below the prior close.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"SYMBIOTEC_PHARMALAB_LTD_52_Week_High_Streak_Consecutive_High_Analysis-2\"><\/span><strong>SYMBIOTEC PHARMALAB LTD 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>SYMBIOTEC PHARMALAB LTD\u2019s 52 Week High Streak is now a second straight session event, and that matters because it shows continuity rather than a one-off print. The cumulative rise of 2.58% across the streak is the clearest measure of how far the stock has moved over these consecutive sessions. In practical terms, the current fresh 52-week high of Rs 1,198.95 is not just a single-session marker; it is the top of a two-day sequence that began on 30 September 2026 and repeated on the next trading session.<\/p>\n<p>The latest Univest figures show a narrow daily move on the latest session even as the yearly-high pattern continued. That mix is useful for readers following SYMBIOTEC 52 Week High Streak: the stock did not need a large single-day jump to keep setting new peaks.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Highs_Show\"><\/span><strong>What the Repeated 52-Week Highs Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Repeated yearly highs tell a different story from an isolated breakout because they show that the stock has held above its prior peak for more than one session. In this case, SYMBIOTEC 52 Week High Streak points to a short run where the market has kept the price near a new one-year top instead of slipping back immediately below it. The cumulative gain matters here because it captures the full streak, not just the latest tick.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Latest_News_Around_SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC\"><\/span><strong>Latest News Around SYMBIOTEC PHARMALAB LTD (SYMBIOTEC)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div class=\"news-context\">According to recent news reports, one item in the last 24 hours may be relevant to the latest move. Symbiotec Pharmalab\u2019s subsidiary, Knovea, entered into a partnership with a major global pharmaceutical company for US sales of two dual chamber vial products. The report, dated 30 Sept, 08:28 pm, says the collaboration could expand market reach and revenue streams for Symbiotec Pharmalab. The market data itself does not establish a single confirmed cause for the repeated yearly highs.<\/div>\n<h2><span class=\"ez-toc-section\" id=\"SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC_Fundamental_Analysis\"><\/span><strong>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,353.15 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">68.76x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 233.38<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) fundamental metrics show P\/E 68.76x, P\/B 5.04x, ROE 11.22%, ROCE 12.41%. Taken on their own, these numbers offer context rather than a trading signal.<\/p>\n<p>SYMBIOTEC PHARMALAB LTD has a market capitalisation of Rs 7,353.15 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 68.76x, P\/B at 5.04x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.22% and ROCE of 12.41%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.1, book value per share of Rs 233.38, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 32.01x, median ROE of 11.74%, median ROCE of 13.63%. They set out the fundamental picture and are not a rating on the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">68.76x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.01x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.06x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.4x to 688.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.92x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.74%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.63%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,353.15 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 765.11 crore<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P\/E ratio of 68.76x, which is above the benchmark median of 32.01x, a difference of +114.81%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROE of 11.22%, which is below the benchmark median of 11.74%, a difference of -4.43%. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROCE of 12.41%, which is below the benchmark median of 13.63%, a difference of -8.95%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/innovacap\/innova-captab-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Innova Captab Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INNOVACAP<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,282.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">42.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.84<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.04<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/blissgvs\/bliss-gvs-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Bliss GVS Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BLISSGVS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,550<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">54.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sanofi\/sanofi-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sanofi India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SANOFI<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,072.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.53<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">44.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">55.46<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/supriya\/supriya-lifescience-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Supriya Lifescience Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUPRIYA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,652.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.58<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/morepenlab\/morepen-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Morepen Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MOREPENLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6,509.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">49.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.19<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P\/E ratio of 68.76x compared with the displayed peer median of 42.4x. The comparison is relative and should not be read as a recommendation. Its ROE of 11.22% compares with a peer median of 13.75% across the companies shown in the table. ROCE stood at 12.41% versus the displayed peer median of 17.4%, providing a capital-efficiency comparison. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a market capitalisation of Rs 7,353.15 crore. Among the 5 peers shown, 2 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_SYMBIOTEC_PHARMALAB_LTD\"><\/span><strong>Why Investors Are Watching SYMBIOTEC PHARMALAB LTD<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>SYMBIOTEC 52 Week High Streak is now two sessions long, which makes the pattern more persistent than a single breakout.<\/li>\n<li>The cumulative move across the streak is 2.58%, giving a clearer read on the full run than today\u2019s small change alone.<\/li>\n<li>The latest 52-week high of Rs 1,198.95 is the same as the session high, which keeps the yearly-high pattern intact.<\/li>\n<li>The stock\u2019s P\/E of 68.76 now sits well above the industry median after the streak move.<\/li>\n<li><\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_SYMBIOTEC_PHARMALAB_LTD\"><\/span><strong>About SYMBIOTEC PHARMALAB LTD<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>SYMBIOTEC PHARMALAB LTD operates in the Pharmaceuticals &amp; Drugs industry within Healthcare, and the current SYMBIOTEC 52 Week High Streak puts that business profile in immediate market focus. The company\u2019s market capitalisation is Rs 7,353.15 crore, which places it among the better-known names in the industry set being tracked here. The current move should be read through the lens of price, valuation and sector comparison rather than as a broad business commentary.<\/p>\n<p>For readers, the useful business context is that the company has a market-facing presence large enough to be compared with other listed pharmaceutical names in the same industry, while the streak has lifted the valuation discussion to the centre of the narrative. That is why SYMBIOTEC 52 Week High Streak matters: it changes the way the market is pricing the company even when the business description itself is unchanged.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_SYMBIOTEC_PHARMALAB_LTD_on_Univest\"><\/span><strong>Track SYMBIOTEC PHARMALAB LTD on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Follow SYMBIOTEC PHARMALAB LTD on Univest to watch how the fresh 52-week high streak develops from here. The current focus is on whether the stock can keep trading near its yearly high, how the valuation compares with industry peers, and whether the next sessions extend the run or narrow it. SYMBIOTEC 52 Week High Streak remains the key theme for readers tracking the stock.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"How_many_sessions_has_SYMBIOTEC_PHARMALAB_LTD_been_at_a_fresh_52-week_high\"><\/span><strong>How many sessions has SYMBIOTEC PHARMALAB LTD been at a fresh 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SYMBIOTEC PHARMALAB LTD has now set a fresh 52-week high for its second straight session. That makes the current event a two-session SYMBIOTEC 52 Week High Streak rather than a single-day breakout.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_cumulative_move_across_the_SYMBIOTEC_52_Week_High_Streak\"><\/span><strong>What is the cumulative move across the SYMBIOTEC 52 Week High Streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The cumulative move across the streak is 2.58%. That figure captures the full two-session run and is more useful here than looking only at the latest intraday change.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_52-week_high_for_SYMBIOTEC_PHARMALAB_LTD\"><\/span><strong>What is the latest 52-week high for SYMBIOTEC PHARMALAB LTD?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest 52-week high is Rs 1,198.95. In the current session, that level also matched the intraday high, so the yearly peak and session peak were the same.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_SYMBIOTEC_PHARMALAB_LTD_trade_around_the_prior_close\"><\/span><strong>How did SYMBIOTEC PHARMALAB LTD trade around the prior close?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock last traded at Rs 1,173.90 versus the previous close of Rs 1,176.05, a decline of Rs 2.15 or 0.18%. The move was modest, even though the broader streak remained intact.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_the_latest_data_confirm_a_company-specific_catalyst\"><\/span><strong>Did the latest data confirm a company-specific catalyst?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>A recent partnership report involving the subsidiary Knovea may be relevant, but the price pattern itself does not prove causation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_SYMBIOTEC_compare_with_the_industry_on_valuation\"><\/span><strong>How does SYMBIOTEC compare with the industry on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Its P\/E of 68.76 is above the industry median of 32.01, while its P\/B of 5.04 is above the industry median of 2.92. After the streak, the stock is valued richer than the middle of the industry set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_SYMBIOTEC_52_Week_High_Streak\"><\/span><strong>What should investors monitor next in SYMBIOTEC 52 Week High Streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can monitor whether the stock keeps holding near the new yearly high, how the valuation compares with peers after each session, and whether any fresh business update aligns with the repeated-high pattern.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_the_repeated_52-week_high_more_important_than_a_one-day_breakout\"><\/span><strong>Why is the repeated 52-week high more important than a one-day breakout?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> A repeated high shows that the stock has reset its yearly peak on more than one session. That makes the move more informative for readers tracking SYMBIOTEC 52 Week High Streak than a single intraday print would be.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC_Share_Price_on_Univest\"><\/span><strong>Track SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/symbiotec\/symbiotec-pharmalab-ltd-share-price-today\">SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"How many sessions has SYMBIOTEC PHARMALAB LTD been at a fresh 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SYMBIOTEC PHARMALAB LTD has now set a fresh 52-week high for its second straight session. That makes the current event a two-session SYMBIOTEC 52 Week High Streak rather than a single-day breakout.\"}},{\"@type\":\"Question\",\"name\":\"What is the cumulative move across the SYMBIOTEC 52 Week High Streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The cumulative move across the streak is 2.58%. That figure captures the full two-session run and is more useful here than looking only at the latest intraday change.\"}},{\"@type\":\"Question\",\"name\":\"What is the latest 52-week high for SYMBIOTEC PHARMALAB LTD?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The latest 52-week high is Rs 1,198.95. In the current session, that level also matched the intraday high, so the yearly peak and session peak were the same.\"}},{\"@type\":\"Question\",\"name\":\"How did SYMBIOTEC PHARMALAB LTD trade around the prior close?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock last traded at Rs 1,173.90 versus the previous close of Rs 1,176.05, a decline of Rs 2.15 or 0.18%. The move was modest, even though the broader streak remained intact.\"}},{\"@type\":\"Question\",\"name\":\"Did the latest data confirm a company-specific catalyst?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No confirmed company-specific catalyst is established by the market data alone. A recent partnership report involving the subsidiary Knovea may be relevant, but the price pattern itself does not prove causation.\"}},{\"@type\":\"Question\",\"name\":\"How does SYMBIOTEC compare with the industry on valuation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Its P\/E of 68.76 is above the industry median of 32.01, while its P\/B of 5.04 is above the industry median of 2.92. After the streak, the stock is valued richer than the middle of the industry set.\"}},{\"@type\":\"Question\",\"name\":\"What should investors monitor next in SYMBIOTEC 52 Week High Streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors can monitor whether the stock keeps holding near the new yearly high, how the valuation compares with peers after each session, and whether any fresh business update aligns with the repeated-high pattern.\"}},{\"@type\":\"Question\",\"name\":\"Why is the repeated 52-week high more important than a one-day breakout?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"A repeated high shows that the stock has reset its yearly peak on more than one session. That makes the move more informative for readers tracking SYMBIOTEC 52 Week High Streak than a single intraday print would be.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SYMBIOTEC PHARMALAB LTD Share Price hit a fresh 52-week high of Rs 1,198.95 today and is trading at Rs 1,173.90, down 0.18% on the day. Market cap stands at Rs 7,353.15 crore.<\/p>\n","protected":false},"author":35,"featured_media":282128,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-282130","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["282128"],"rank_math_title":["SYMBIOTEC 52 Week High Streak: Valuation, Peers, Context"],"rank_math_description":["SYMBIOTEC PHARMALAB has now set a fresh 52-week high for a second straight session. Here is the streak, valuation, sector context and peer view."],"rank_math_focus_keyword":["SYMBIOTEC 52 Week High Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/SYMBIOTEC_PHARMALAB_SYMBIOTEC_52_Week_High_Streak_Second_Straight_Session_bullish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282130","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=282130"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282130\/revisions"}],"predecessor-version":[{"id":282132,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282130\/revisions\/282132"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/282128"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=282130"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=282130"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=282130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}